Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Hayes

Showing results (191-200 of 238) with videos related to

Pageof 24
Sort By:
Plos One|December 19, 2013
Deciphering the complex distribution of human immunodeficiency virus type 1 subtypes among different cohorts in Northern TanzaniaHarr F Njai, Fiona M Ewings, Eric Lyimo, et al.
The Journal of Infectious Diseases|December 18, 2012
Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-Seronegative African girls and young womenPapa Salif Sow, Deborah Watson-Jones, Nancy Kiviat, et al.
The Lancet. HIV|November 4, 2022
Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trialEthan Wilson, Deborah Donnell, Timothy Skalland, et al.
PLOS Global Public Health|June 1, 2026
Migration and its impact on universal HIV testing and treatment in the HPTN 071 (PopART) study communitiesDavid Macleod, Sian Floyd, Kwame Shanaube, et al.
SSM - Population Health|August 14, 2023
The effect of universal testing and treatment for HIV on health-related quality of life - An analysis of data from the HPTN 071 (PopART) cluster randomised trialKatherine Davis, Michael Pickles, Simon Gregson, et al.
Journal of the International AIDS Society|January 10, 2018
Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan AfricaDelphine Perriat, Laura Balzer, Richard Hayes, et al.
Trials|April 7, 2021
How 'place' matters for addressing the HIV epidemic: evidence from the HPTN 071 (PopART) cluster-randomised controlled trial in Zambia and South AfricaVirginia Bond, Graeme Hoddinott, Lario Viljoen, et al.
Journal of the International AIDS Society|October 27, 2023
Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)Wendy Grant-McAuley, Estelle Piwowar-Manning, William Clarke, et al.
Health Policy and Planning|July 5, 2016
HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South AfricaJames R Hargreaves, Anne Stangl, Virginia Bond, et al.
Plos Neglected Tropical Diseases|July 15, 2020
Genital self-sampling compared with cervicovaginal lavage for the diagnosis of female genital schistosomiasis in Zambian women: The BILHIV studyAmy S Sturt, Emily L Webb, Comfort R Phiri, et al.
Pageof 24

Showing results (191-200 of 238) with videos related to

Sort By:
Pageof 24
Plos One|December 19, 2013
Deciphering the complex distribution of human immunodeficiency virus type 1 subtypes among different cohorts in Northern TanzaniaHarr F Njai, Fiona M Ewings, Eric Lyimo, et al.
The Journal of Infectious Diseases|December 18, 2012
Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-Seronegative African girls and young womenPapa Salif Sow, Deborah Watson-Jones, Nancy Kiviat, et al.
The Lancet. HIV|November 4, 2022
Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trialEthan Wilson, Deborah Donnell, Timothy Skalland, et al.
PLOS Global Public Health|June 1, 2026
Migration and its impact on universal HIV testing and treatment in the HPTN 071 (PopART) study communitiesDavid Macleod, Sian Floyd, Kwame Shanaube, et al.
SSM - Population Health|August 14, 2023
The effect of universal testing and treatment for HIV on health-related quality of life - An analysis of data from the HPTN 071 (PopART) cluster randomised trialKatherine Davis, Michael Pickles, Simon Gregson, et al.
Journal of the International AIDS Society|January 10, 2018
Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan AfricaDelphine Perriat, Laura Balzer, Richard Hayes, et al.
Trials|April 7, 2021
How 'place' matters for addressing the HIV epidemic: evidence from the HPTN 071 (PopART) cluster-randomised controlled trial in Zambia and South AfricaVirginia Bond, Graeme Hoddinott, Lario Viljoen, et al.
Journal of the International AIDS Society|October 27, 2023
Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)Wendy Grant-McAuley, Estelle Piwowar-Manning, William Clarke, et al.
Health Policy and Planning|July 5, 2016
HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South AfricaJames R Hargreaves, Anne Stangl, Virginia Bond, et al.
Plos Neglected Tropical Diseases|July 15, 2020
Genital self-sampling compared with cervicovaginal lavage for the diagnosis of female genital schistosomiasis in Zambian women: The BILHIV studyAmy S Sturt, Emily L Webb, Comfort R Phiri, et al.
Pageof 24